Administering insulin and monitoring glucose levels can be just as expensive as the insulin itself. A bill in Rhode Island is ...

A quarter-size device that tracks the rise and fall of sugar in your blood is the latest source of hope — and hype — in the growing buzz around wearable health technology. Continuous glucose monitors, ...

Emerging evidence points to potential benefits of continuous glucose monitoring (CGM) well beyond use as a management tool for people with diabetes who use insulin. Until recently, CGM use had been ...

The U.S. Food and Drug Administration (FDA) is issuing an Early Alert for specific glucose monitoring systems after Abbott ...

At the 18th International Diabetes Federation Congress (IDF) symposium on "Insulin Delivery Devices and Glucose Sensors," [1] Theodor Koschinsky, MD, University of Dusseldorf, Germany, discussed the ...

The Food and Drug Administration has identified a Class I recall of certain FreeStyle Libre 3 and FreeStyle Libre 3 Plus ...

This diabetes technology offers a continuous stream of data to show a more complete picture of your blood sugars over time. This is different from a fingerstick meter that only represents that moment.

The consensus is emerging that public health surveys based solely on HbA1c may misrepresent India's diabetes burden.

Experts warn that relying solely on HbA1c for diagnosing type-2 diabetes in India may lead to misleading results.

A Lancet Regional Health study warns that HbA1c, India's most used diabetes test, may misdiagnose or delay detection due to ...

Abbott Diabetes Care has recalled some of its FreeStyle Libre 3 and FreeStyle Libre 3 Plus glucose monitor sensors for people ...